Antifungal Drugs in Newborns and Children

Abstract

Invasive fungal infections are a significant cause of morbidity and mortality in infants and children. Early diagnosis is critical, and treatment with the appropriate drug and dose should be initiated promptly. Although an increasing number of studies have examined dosing of antifungals in this population, pediatric safety and efficacy data are lacking.

Keywords: Antifungal agents; Children; Immunocompromised hosts; Newborns.